Avantor: The Q4 Dip Could Have Priced In All The Negatives

Company Overview - Avantor (NYSE: AVTR) is a distributor and manufacturer in the life sciences, biotech, and pharmaceuticals sectors, supplying laboratories, research facilities, and drug manufacturers with millions of consumables and equipment [1] Investment Focus - The investment strategy emphasizes companies that pay healthy dividends and have clear potential for capital appreciation, focusing on businesses that reward shareholders [1] Valuation Criteria - The shares of the company should be temporarily undervalued relative to its fundamentals, peers, and historical levels, with high odds for capital appreciation driven by foreseeable catalysts [1]